Mycophenolate vs Azathioprin in Autoimmune Hepatitis

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

A study with 20 de novo patients with autoimmune hepatitis, 10 receiving azathioprin and 10 receiving mycophenolat mofetil.

Phase 4

Rigshospitalet, Denmark